Status:
COMPLETED
Mortality Related to AMR in Patients With Hospital-acquired Infection
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
Sanpasitthiprasong Hospital
Mahidol Oxford Tropical Medicine Research Unit
Conditions:
Hospital-acquired Infections
Eligibility:
All Genders
Brief Summary
This is a prospective surveillance study to estimate excess deaths due to and risk factors associated with antibiotic-resistant infection among patients with hospital-acquired infection (HAI) in a res...
Detailed Description
We will first identify patients with pathogenic bacteria isolated from clinical sample collected \>48 hours after admission. These patients will then be screened for eligibility criteria. Signed infor...
Eligibility Criteria
Inclusion
- Male or female of any age admit at Sunpasitthiprasong Hospital
- At least one of the six organisms, which include Staphylococcus aureus, Enterococcus spp., Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter spp., isolated from clinical specimen \>48 hours after admission
- Acquired Bloodstream infection (BSI), Lower-respiratory tract infection(LRTI), Skin/Soft tissue infection (SSTI), Surgical-site infection (SSI), Urinary tract infection (UTI) or infection at other body sites \>48 hours after admit at the hospital
Exclusion
- • Clinical symptoms of current infection presented ≤48 hours of admission
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
2069 Patients enrolled
Trial Details
Trial ID
NCT03411538
Start Date
March 1 2018
End Date
February 28 2020
Last Update
September 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunpasitthiprasong Hospital
Ubon Ratchathani, Thailand, 34000